Bilirubin as a Therapeutic Molecule: Challenges and Opportunities

por Adin, Christopher A.
Publicado 2021

The Diabetic Dog as a Translational Model for Human Islet Transplantation


por Adin, Christopher A., Gilor, Chen
Publicado 2017

Safety, Tolerability, and Proof-Of-Concept Study of OKV-119, a Novel Exenatide Long-Term Drug Delivery System, in Healthy Cats

por Klotsman, Michael, Adin, Christopher A., Anderson, Wayne H., Gilor, Chen
Publicado 2021

Selective Osmotic Shock for Islet Isolation in the Cadaveric Canine Pancreas

por Thompson, Elizabeth M., Sollinger, Jennifer L., Opara, Emmanuel C., Adin, Christopher A.
Publicado 2018

Nano-Encapsulation of Bilirubin in Pluronic F127–Chitosan Improves Uptake in β Cells and Increases Islet Viability and Function after Hypoxic Stress

por Fullagar, Bronwyn, Rao, Wei, Gilor, Chen, Xu, Feng, He, Xiaoming, Adin, Christopher A.
Publicado 2017

In Vitro Evaluation of a Novel Synthetic Bilirubin Analog as an Antioxidant and Cytoprotective Agent for Pancreatic Islet Transplantation

por Luckring, Emilee J., Parker, Patrick D., Hani, Homayoun, Grace, Mary H., Lila, Mary A., Pierce, Joshua G., Adin, Christopher A.
Publicado 2020

Thermogenic crosstalk occurs between adipocytes from different species

por Gilor, Chen, Yang, Kefeng, Lee, Aejin, Song, No-Joon, Fadda, Paolo, Adin, Christopher A., Herbert, Claire, Jennings, Ryan, Ham, Kathleen, Lee, James, Ziouzenkova, Ouliana
Publicado 2019

Prevalence of Glomerulopathies in Canine Mammary Carcinoma

por Crivellenti, Leandro Z., Silva, Gyl E. B., Borin-Crivellenti, Sofia, Cianciolo, Rachel, Adin, Christopher A., Dantas, Márcio, dos Anjos, Denner S., Tinucci-Costa, Mirela, Santana, Aureo E.
Publicado 2016

Glomerulotubular pathology in dogs with subclinical ehrlichiosis

por Crivellenti, Leandro Zuccolotto, Cintra, Cristiane Alves, Maia, Suellen Rodrigues, Silva, Gyl Eanes Barros, Borin-Crivellenti, Sofia, Cianciolo, Rachel, Adin, Christopher A., Tinucci-Costa, Mirela, Pennacchi, Caio Santos, Santana, Aureo Evangelista
Publicado 2021